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Abstract. 1 ,2-Dichloroethane (DCE) was reported to be 
carcinogenic in rats in a long-tenn bioassay using gavage 
in com oil (24 and 48 mg/kg/day), but not by inhalation (up 
to 150-250 ppm, 7 h/day, 5 days/week). The daily dose 
metabolized was similar in the two experiments. In order to 
address this discrepancy, the genotoxicity of DCE was 
investigated in vivo under different exposure conditions. 
Fernale F-344 rats (183-188 g) were exposed to [1,2-14C]-
DCE in a closed inhalation chamber to either a low, con-
stant concentration (0.3 mg/l = 80 ppm for 4 h) or to a peak 
concentration (up to 18 mg/1 = 4400 ppm) for a few 
minutes. After 12 h in the chamber, the dose metabolized 
under the two conditions was 34 mg/kg and 140 mg/k:g. 
DNA was isolated from liver and lung and was purified to 
constant specific radioactivity. DNA was enzymaticaBy 
hydrolyzed to the 3' -nucleotides which were separated by 
reverse phase HPLC. Most radioactivity eluted without 
detectable or with little optical density' indicating that the 
major part of the DNA radioactivity was due to covalent 
binding of the test compound. The Ievel of DNA adducts 
was expressed in the dose-nonnalized units ofthe Covalent 
Binding Index, CBI = f.Lmol adduct per mol DNA nu-
cleotide/mmol DCE per kg body wt. In liver DNA, the 
different exposure regimens resulted in markedly different 
CBI values of 1.8 and 69, for "constant-low" and ''peak" 
DCE exposure Ievels. In the Jung, the respective values 
were 0.9 and 31. It is concluded that the DNA darnage by 
DCE depends upon the concentration-time profile and that 
the carcinogenic potency determined in the gavage study 
should not be used for low-Ievel inhalation exposure. 
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lntroduction 
Two carcinogenicity sturlies have been performed with 
1 ,2-dichloroethane (DCE). Apart from strain differences, 
the major disparity in methodology was the route of appli-
cation. While the NCI study (NCI 1978) used oral gavage, 
the Bologna Tumor Center study (Maltoni et al. 1980) used 
inhalation. 
The NCI bioassay showed a significant increase in a 
variety of tumors in Osbome-Mendel rats and B6C3Fl 
mice, including squamous cell carcinoma of the fore-
stomach and hemangiosarcoma in male rats, adenocarci-
noma of the mammary gland in female rats, mammary 
adenocarcinoma in female mice and alveolar and bronchi-
olar adenoma in mice of both sexes. Tumorigenic poten-
cies ofDCE expressedas TDso values were estimated tobe 
7 mg DCE/kg/day in rats and about 70 mg DCE/kg/day in 
mice (Hooper et al. 1980). 
Exposing Sprague-Dawley rats and Swiss mice to 5, 10, 
50 or 150-250 ppm DCE, 7 h per day, 5 days per week, 
for 78 weeks, the inhalation study failed to produce any 
evidence of treatment-related tumor induction (Maltoni et 
al. 1980). The summary TDso were >297 and >86, >4050 
and >1210 mg DCE/kg/day formale and female rats, and 
male and female mice, respectively (Hooper et al. 1980). 
DCE was weakly but reproducibly mutagenic in Sal-
monella typhimurium (WHO 1987) without metabolic acti-
vation. A stronger positiveresponsein TA 1535 and TA 
100 resulted from the presence of a Ii ver metabolic activa-
tion system due to conjugation with glutathione, catalyzed 
by glutathione S-transferase (Rannug 1980; van Bladeren 
et al. 1981). 
The potential for covalent binding of DCE to DNA in 
vivo was investigated by several authors (Reitz et al. 1982; 
Arfellini et al. 1984; Inskeep et al. 1986). Following i.p. 
administration of DCE to Sprague-Dawley rats, the major 
DNA adduct fonned in the liver was S-[2-(guanyl-7)-
ethyl]gJutathione (lnskeep et al. 1986). Thus, glutathione 
conjugation has resulted in an electrophilic intermediate 
[the half-mustard S-(2-chloroethyl)glutathione and the epi-
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sulfonium ion derived] which can react with nucleophilic 
centers in DN A. 
In view of the complex activation and inactivation 
processes goveming the fonnation of DNA binding, the 
possibility was considered that different blood Ievels could 
result in quantitative metabolic differences and different 
Ievels of genotoxicity. Some infonnation along this line 
was deduced from the work of Storer et al. (1984) with 
mice. They reported on single-strand breaks induced in 
liver DNA after oral and intraperitoneal administration of 
DCE (100-150 mg/kg) but not after inhalation at up to 
500ppm. 
Administration of DCE by oral gavage or by injection 
results in peak blood Ievels, whereas inhalation exposure to 
constant concentrations produces a steady burden of the 
organism. With exposure in a closed inhalation chamber, 
different concentration-time profiles can be generated to 
simulate the difference between peak-like administration 
and continuous low-level exposure. Wehave therefore in-
vestigated whether DNA adduct formation by DCE in rats 
is dependent on the concentration-time course during in-
halation, the most important route of human exposure. One 
group of rats was exposed to a continuous low concentra-
tion of [14C]DCE in the atmosphere. Another group was 
exposed to high initial concentrations of [14C]DCE in the 
atmosphere, leading to high peak blood Ievels of DCE. 
After 12 h, the Ievel of DNA adducts was determined in 
liver and lung and expressed per dose metabolized, in the 
units of the Covalent Binding Index (CBI). 
Materials and methods 
Test compound 
UnlabeJJed DCE from Merck, Dannstadt, FRG, had a purity of >99.3% 
as determined by gas chromatography. Four ampoules, each containing 
6.2 mg (0.50 mCi; 8.0 mCi/mmol) [1,2- 14C)DCE (Lot Nr. 107F9253) 
were obtained from Pathfinder Laboratories, Sigma Chemical Company, 
St Louis, Missouri. Three months before use, gas chromatography per-
fonned by Pathfinder Laboratories had demonstrated a radiochemical 
purity exceeding 98%. In order to check the radiochemical purity at the 
time of administration, air samples were taken from the inhalation cham-
ber and injected in 1 ml ampoules containing 50% aqueous methanol. 
Aliquots were subjected to HPLC separations on a Lichrosphere RP 18 
Fig. 1. Sehemarie representation of the closed 
inhalation chamber used. The components are: 
A, chamber with a volume of 2.03 1 (net gas 
volume 1.85 I); B, soda lime to adsorb carbon 
dioxide; C, manometer. The chamber A was 
maimained at a negative pressure determined 
by the different filling Ievels in G; D, oxygen 
inlet; E, water bottle; F, septum holder; G, irn-
pingers regulating the oxygen supply; H, 
U-tube for freezing out and subsequent applica· 
tion of the test compound 
(5 Jlm) column, eluted with methanol/water (l+l) at a flow rate of 
1.5 ml/min. Fractions of 1 min were collected and counted for radioactiv-
ity after addition of 10 ml Insta-Gel (Packard) in a Packard scintillation 
counter Tricarb 460 CD. A total of 99% of the eluted radioactivity was 
found within one peak at the DCE retention time. 
Animals 
Fernale F-344 rats [CDF(F-344)/CrlBR] were obtained from Charles 
River Wiga, Sulzfeld, FRG. with weights in the range of 146-150 g. 
They were held two per macrolone cage on sawdust for 1 month of 
acclimatisation. They were fed Haltungsdiät "A" No. 343, Klingental 
MUhle AG, Kaiseraugst, Switzerland, ad libitum and bad free access to 
tap water. 
Closed inhalation chamber 
A closed inhalation system described by Bolt et al. ( 1976) and modified 
according to Lutz and Schlaner (1978) was used (Fig. 1). TI1e CO-! 
exhaled by the animal was adsorbed on soda lime. The resulting reduced 
pressure was balanced by a supply of oxygen. This gas flow was also 
used for the transport of DCE frorn the U-tube (H) into the chamber. 
DCE had first been trapperl in the U-tube (H): the ampoules containing 
radioactive DCE were cooled with liquid nitrogen, operred and quickly 
enclosed in a round bottomed flask. For the exposures to "peak" concen-
trations, the flask also contained the unlabelled DCE. The flask was 
connected to the U-tube on a vacuum lipe. At a pressure of about 103 Pa, 
a waiting period of 30 min was sufficient for complete transfer and 
freezing out of the compound. The two teflon screw Stoppers of the 
U-tube were closed, the tubewas disconnected from the vacumm line and 
connected to the by-pass in the oxygen supply stream. 
Treatments 
Two different types of exposure were used: 
a) "Constant-low" exposure. With rats nos 1 and 2, the U-tube (Hin 
Fig. 1) containing 6.2 mg (0.50 mCi) [l4C]DCE was immersed in an 
ethanol bath kept at a temperature between -45• C and -55. C by adding 
liquid nitrogen; 
b) "Peak" exposure. In the exposures of rats nos 3 and 4, 6.2 mg 
(0.50 mCi) [14C]DCE together with 42.9 or 45.4 mg inactive DCE was 
placed in the U-tube and heated to 30· C in a water bath. 
After placing a rat in the chamber and waiting for a few minutes until 
the pressure started to fall, the teflon three-way valves of (D) were 
switched to the U-tube while the pressure in the chamber further 
decreased. Oxygen was Iet into the tube by opening the right-hand screw 
stopper of (H) and finally, by opening the other Stopper, the reduced 
pressure in the chamber was brought back to normal by the stream of 
oxygen carrying the DCE along. 
Kbletics 
At different times after DCE influx, 0.50 ml of the chamber atmosphere 
was withdrawn with a gas-tight syringe and loaded onto the packed 
column (4' x l/8n, DC 200 on CHROM-P) of a gas chromatograph 
GOW-MAC model 750 equipped with FID. A column temperature of 
45" C and a nitrogen carrier gas pressure of 1.0 atm resulted in a retention 
time for DCE of 2 min. Amber glass bottles capped with rubber septa and 
containing different amounts of unlabelled DCE served as calibmtion 
Standards. 
At the end of the inhalation exposures to Iabeiied DCE, one half of 
the chamber was cleaned with a paper towel containing toluene and 
counted for radioactivity. Less than 0.005% of the applied radioactivity 
was found to be adsorbed on the inner glass surface of the chamber. The 
fur of the animals retained less than 1% of the dose metabolized, as 
detennined by scintillation counting of a small area of fur. 
Metabolized dose 
In the situation with "constant-low" exposure, rats completeley metabo-
lized the DCE placed in the U-tube and no DCE was detected in the 
chamber atmosphere at the end of the experiment. With "peak" exposure 
to a I arger exposure dose, some DCE remained in the chamber at the end 
ofthe treatment, indicating that the metabolism was not complete. In this 
case, the DCE dose metäbolized was estimated as illustrated in Fig. 2. 
For rat no. 3, for instance, the total amount of DCE in the U-tube was 
49.1 mg. The amount of DCE in the chamber atmosphere was calculated 
from the measured concentrations and the chamber volume. lt dropped 
from 7.80 to 4.36 mg between 206 and 716 min. At time 0, and under the 
assumption of a zero-order decrease, 9.1 mg DCE are calculated for the 
chamber atmosphere. Basedon a total of 49.1 mg DCE available at time 
zero, a ratio 40: 9 = 4.4 follows for the equilibrium partition between rat 
and chamber atmosphere. Using this mtio, the amount of DCE in the 
animal can be calculated for the time of death t = 732 min tobe 18.2 mg. 
After deduction of the DCE residue remaining in the chamber, the 
metabolized dose amounts to 26.8 mg. 
Isolation of DNA 
After 12 h in the inhalation chamber, the animals were killed by open 
heart puncture under ether anaesthesia. Livers and lungs were excised 
and homogenized in a teflon Potter-Eivehjem-type homogenizer at 4 • C. 
DNA was isolated according to Sagelsdorff et al. (1983). Essentially, 
chromatin was precipitated with a non-ionic detergent and the pellets 
were washed until the Suspensions contained less than 1 !J.Ci total radio-
activity in order to remove the majority of non-covalently bound radioac-
tivity. Half of the chromatinpellet was homogenized in a lysing medium 
deproteinated with chlorofonn/isoamyl alcohol/phenol (CIP). Phenol 
was removed with diethylether, and the DNA was purified by adsorption 
on a hydroxylapatite column, dialysis, and precipitation with ethanol. 
The highly purified DNA was dissolved in 20 mM sodium succinate; 
pH 6.0, containing 8 mM CaCh. The amount of DNA was detennined 
assuming an absorbance of 20 at 260 run for a solution of 1 mg DNNml. 
Scintillation counting was performed on an aliquot of the DN A solution 
after addition of 10 ml Insta-Gel (Packard}. 
For repurification, the DNA solution was mixed with 25 ml lysing 
medium, extracted twice with CIP and diethylether, dialysed and precip-
hated with ethanol. The DNA was dissolved, and the specific radioactiv-
ity of DNA was detennined as described above. 
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Fig. 2. Schematic illustration of the procedure to calculate the metabo-
lized dose in the closed inhalation chamber. The amount of DCE in the 
chamber atmosphere (calculated from the measured concentrations and 
the chamber volume) is extrapolated to time zero. The ratio DCEror to 
DCEchambcr at time zero is used to estimate the amount of DCE metabo-
lized at the time of death, on the assumption of equilibrium conditions for 
DCE between animal and chamber atmosphere. Data points taken from 
rat no. 3 
Control experiments 
Control animals nos 5 and 6 were exposed to unlabelled DCE under 
conditions of "peak" and "constant-low" exposure, respectively. The 
organs were used for the following experiments: 
a) Background radioactivity. DNA was isolated from rat no. 5. The 
radioactivity count - upon comparison with historical controls- was 
used to show that the work-up of the DNA samples was performed 
without external comamination with radiolabel; 
b) Binding in vitro. The chromatinpellet isolated from rat no. 6 was 
incubated at 4 • C for 15 min with the radiolabelled supematant of the first 
chromatin precipitation step of the DNA preparation from radiolabel-
treated animal no. 3. This checks whether radiolabet could bind to or 
contaminate DNA during the process ofDNA isolation. 
Specific actMty of contaminating protein. Chromatinprotein was precip-
itated with acetone from the first CIP extract and dissolved in 1% (w/v) 
aqueous SOS. Precipitation and solution steps were repeated 4 times. The 
lastsolutionwas diluted to 0.1% SDS and 1 ml was used for the scintil-
lation counting. The amount of protein was detennined with the Folin 
reagcnt. 
Analysis of nucleotides by reverse phase chromatography 
DNA in 8 mM CaCh, 20 mM sodium succinate buffer, pH 6.0, was 
digested enzymatically with micrococcal endonuclease (Sigma 
no. N3755; E. C. 3.1.31.1.; 5 units/mg DNA) and spieen exonuclease 
(Boehringer Mannheim no. 108251; E. C. 3.l.l6.1; 0.05 units/mg DNA) 
for 16-18 h at 37· C. The resulting nucleotide mixture was separated by 
HPLC on a Lichrosorb RP 18 (7 )..lm) column (8 mm x 250 mm), eluted 
with 10 mM ammonium fonnate buffer, pH 5.8 containing 3% methanol 
for 10 min, followed by a linear gradient to 100% methanol in 40 min. 
The flow rate was 3.5 ml/min. The optical density was recorded at 
254 nm. In general, fractions of 2 min were collected. In the regions of 
the natural nucleotides the fractions were taken manually whenever 
optical density appeared. The retention times for the natuml deoxynu-
cleotides, deoxycytidine-3' -monophosphate, deoxyguanosine-3' -mono-
phosphate, thymidine-3'-monophosphate and deoxyadenosine-3'-mono-
phosphate (abbreviated to dCp, dGp, Tp and dAp) were 4, 5, 6, and 
12 min, respectively. 
The concentration of each deoxynucleotide in the fractions was deter-
mined by UV spectroscopy before Insta-Gel was added. Optical densities 
of 29, 38, 29, and 44 for I mglml dCp, dGp, Tp, and dAp, respectively, 
were used. For the mixture of nucleosides obtained from DNA, a value of 
30 was used. Methanol or water was added to provide homogeneaus 
samples for liquid scintillation counting in 10 ml Insta-GeL 
The background radioactivity was determined from an analysis of an 
unlabeled DNA digest. The Iimit of detection of {14C]radioactivity in a 
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Fig. 3. Time-course of the DCE concentration in the inhalation chamber 
with rat no. 2. The U-tube of the inhalation system was cooled to 
-50 ± s· c to reduce the vapour pressure and slow down the transporta-
tion rate of radiolabelled DCE into the chamber. A concentration of 
0.3 mg/1 corresponds to 80 ppm 
fraction was 1.8 cpm above background (at the Ievel of 2 standard devia-
tions). This figure was derived from the statistics of radioactivity count-
ing (2 SD = 0.8 cpm at 3 x 30 min counting time, multiplied with the 
square root of 2 for the difference formed between sample and back-
ground), plus the maximum observed vial-to-vial difference of 0.7 cpm 
(determined with a counting time of 1000 min per vial). 
Calculations 
The Ievel of DNA adduct fonnation was nonnalized to the dose, by 
expression in the units of the Covalent Binding Index (CBJ) = fJmol 
adduct per mol nucleotide/mmol DCE per kg body (Lutz 1979). These 
molar units were calculated from radioactivity data by the following 
conversion: CBI = (dpm DCE as aducts per mg DNA)/(dpm DCE metab-
olized per kg body) x 3.09 x 108 on the basis of an average molecular 
weight of 309 for a nucleotide in DNA. 
Results 
Kinetics and doses metabolized 
"Constant-low" exposure: The slow, steady flow of DCE 
to the chamber resulted in a concentration level of 0.28-
0.35 mg DCE/l air (see Fig. 3 for time-course with rat 
no. 2). Mter the first 4 h, no DCE was left in the U-tube 
and the concentration decreased due to metabolic disap-
pearance of DCE. After 12 h, at the end of the experiment, 
the minute concentration in the chamber atmosphere 
(0.0016 mg DCE/l air) indicated that the entire sample of 
6.2 mg DCE bad been metabolized. 
"Peak" exposure. The concentration-time course of DCE 
in the chamber atmosphere, as seen with rat no. 3, is 
depicted in Fig. 4. Three phases can be distinguished. 
During the frrst 20 min, DCE was transported to the cham-
ber and the DCE concentration increased rapidly. The 
maximum amount of DCE measured in the chamber atmo-
sphere was 34 mg (69% of the chemical placed in the 
U-tube). The next 3 h were govemed primarily by uptake 
and distribution of DCE in the rat. In the last 7 h, a slow 
disappearance from the atmosphere was observed. Phar-
. macokinetic data indicate that this decrease was due to 
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Fig. 4. Time-course of the DCE concentration in the inhalation chamber 
with rat no. 3. In order to achieve a high initial concentration in the 
chamber atmosphere, the U-tube of the inhalation system containing 
radioJabelled DCE was heated to 30" C. A concentration of 18 mg/1 
corresponds to 4400 ppm 
DCE metabolism (Reitz et al. 1982; Spreafico et al. 1980). 
Using the calculation described before (see Fig. 2), rats 
nos. 3 and 4 metabolized 26.8 and 24.9 mg DCE, respec-
tively. 
DNA radioactivity 
Radioactivity was clearly detectable in all DNA samples 
obtained from livers (Table 1) and lungs (Table 2) of 
treated animals. In order to remove radioactivity which 
was not covalently bound, DNA was repurified until the 
specific radioactivity remained constant within ± 10% 
(twice for liver; once for lung). ' 
Radioactivity associated with DNA isolated from an 
animal that has been treated with a radio Iabelied substance 
is not necessarily due ,to covalent interactions of the test 
compound with DNA. It could be derived from additional 
sources: 
(i) Interaction of the test compound and its metabolites 
with DNA during the isolation procedure. This contribu-
tion must be small because the data of the respective con-
trol experiments· given in the column headed "Binding in 
vitro" of Tables 1 and 2 show that the radioactivity of the 
DNA arising from the work-up was not significantly mea-
surable. 
(ii) Contamination of DNA with protein. DCE and its radi-
olabelled metabolites interacted with chromatin protein. 
The specific radioactivities ranged between 1000 and 
1600 dpm/mg protein in the liver and between 400 and 
1100 dpm/mg in the lung. This was not more than a factor 
of 20 higher than the specific activity encountered in DNA. 
In view of the maximum possible contamination of our 
DNA with 0.2% protein (Caviezel et al. 1984), the specific 
radioactivities were too low for protein contamination to 
contribute substantially to the DNA radioactivity. 
(iii) Biosynthetic incorporation of radioactivity into DNA 
and protein. This is a more likely source of radioactivity if 
the compound administered is degraded tosmall molecules 
able to enter the pool of nucleic acid precursors. Analysis 
of the nucleotides was required to show to what extent 
incorporation of the radiolabel during DNA synthesis con- . 
tributed to the total DNA radioactivity. 
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Table 1. Radioactivity (RA) in liver DNA isolated from female F-344 mts following 12 h exposure to "constant-low" and "peak" concentrations of 
[ 14C] I ,2-dichloroethane (DCE) by inhalation 
Type of experiment Exposure to "constant-low" 
concentration of [1 4C]DCE 
(see Fig. 3 for time-course) 
Rat no. 1 Rat no. 2 
Animal weight (g) 184 183 
Dose metabolized 
(mg/kg) 33.5 33.7 
RA metabolizcd 
(dpm/kg) 6.03 X JQ9 6.07 X 109 
RA in the Jiver 
(% of total body burden) 2.6 1.6 
DNA Ist purification: 
Amount in vial 
(mgDNA) 0.60 0.38 
Gross RA 
(cpm) 40.6 29.5 
Specific RA 
(dpm/mg)3 55.2 50.8 
DNA 2nd purification: 
Specific RA 
(dpm/mg) 47.9 45.1 
DNA 3rd purification: 
Specific RA 
(dpm/mg) 43.0 42.9 
(CBI units)b 2.2 2.2 
Nucleotide analyses by reverse phase HPLC 
Recovery of RA 
loaded(%) 92 86 
RA in fractions 
with natuml nucleotides 22 18 
(% of total RA eluted) 
RA due to adduct formationc 
(% of total RA eluted) 78 82 
Covalent binding 
(CBI units)b 1.7 1.8 
a The counting efficiency was 79% 
b The Covalent Binding Index (CBI) was defined: 
CBI= 
f..lmol adducts I mol DNA nucleotide 
mmol test compound I kg body weight 
Radiolabel in normal nucleotides 
Enzymatic degradation of the DNA to the deoxyribonu-
cleotide-3' -monophosphates and Separation of the four nat-
ural constituents dCp, dGp, Tp and dAp by reverse phase 
HPLC resulted in reproducible elution profiles where the 
natural deoxyribonucleotides were localized by the use of 
standards and their optical density at 254 nm (Fig. 5). The 
small peaks following dAp represented deoxyribonu-
cleosides obtained from partial loss of the 3' -phosphate 
group from the nucleotides. The [ 14C]radioactivity in each 
fraction was counted. The concentration of the nucleotides 
in the fractions with optical density was measured and 
specific radioactivities were calculated. Radiolabel mea-
Exposure to "peak" concentra- Controls 
tion of [14C]DCE 
(see Fig. 4 for time-course) Background Binding 
radioactivity in vitro 
Ratno. 3 Ratno. 4 Ratno.5 Rat no. 6 
188 188 175 188 
143 133 124 38.0 
3.22 X 109 2.85 X 109 0 0 
5.1 4.8 
0.42 0.56 0.46 0.39 
299 428 14.7 14.4 
849 953 0 0 
723 793 0 0 
656 723 0 0 
63 79 
94 109 
6 0 
94 100 
59 79 
c Sum of the radioactivity in the hatched fractions of Figs. 5 and 6 
sured in fractions with low specific radioactivity was as-
sumed to represent biosynthetic incorporation of the radi-
olabel into the nucleotide skeleton (open bars in Figs. 5 
and 6). The respective fraction ranged from undetectable to 
22% in the liver, and from 6 to 44% in the lung. 
DCE-nucleotide adducts: Covalent Binding Indices 
Formation of DNA adducts alters the retentiontime of the 
modified nucleotides in the HPLC run. Since DCE-nu-
cleotide adducts have the same (high) specific activity as 
DCE administered, they are detectable on the basis of 
radioactivity with little or no optical density. These frac-
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Table 2. Radioactivity (RA) in lung DNA isolated from female F-344 rats following 12 h exposure to "constant low" and "peak." concentrations of 
[ 14C]l,2-dichloroethane (DCE) by inhalation. Animal weight, chemical and radioactivity dose metabolized are given in Table 1 
Type of experiment Exposure to "constant-low" 
concentration of [14C]DCE 
(sce Fig. 3 for time-course) 
RA in the lungs 
(% of total body burden) 
DNA Ist purification: 
Amount in vial 
(mgDNA) 
Grass RA 
(cpm) 
Specific RA 
(dpm/mg)a 
DNA 2nd purification: 
Specific RA 
(dpm/mg)a 
(CBI units)b 
Rat no. 1 Rat no. 2 
0.043 0.041 
0.50 0.35 
26.1 24.6 
28.4 35.2 
28.6 36.0 
1.5 1.8 
Sampies of Rat no. 1 & 2 pooled 
Nucleotide analyses by reverse phase HPLC 
Recovery of RA 
loaded(%) 68 
RA in fractions 
with natural nucleotides 
(% of total RA eluted) 44 
RA due to adduct fonnationc 
(% of total RA eluted) 56 
Covalent binding 
(CBI units)b 0.9 
a. b, c For footnotes see legend to Table I 
tions (emphasized by hatched bars in Figs. 5 and 6) con-
tained 78-100% and 56-94% of the total radioactivity 
eluted in HPLC following hydrolysis of DNA from liver 
and lung, respectively (Tables 1 and 2). The HPLC proflies 
also provided evidence for the presence of structurally 
different DNA adducts, but the separation was limited by 
the nurober of fractions and the counts available. 
In order to nonnalize the DNA darnage to the dose, the 
specific radioactivity attributable to DNA adduct fonna-
tion was now converted to the units of the CBI = (J.lmol 
chemical bound per mol nucleotide/mmol chemical metab-
oJized per kg body weight) (Lutz 1979). The values are 
shown in the last line of Tables 1 and 2. It emerges that 
exposure to a "peak" concentration resulted in much higher 
DNA binding potency of DCE than "constant-low" con-
centration, both for liver (69 versus 1.8) and for lung (31 
versus 0.9). 
Discussion 
DNA binding potency 
Wehave shown that the potency of DNA adduct fonnation 
in rats after inhalation of DCE is strongly dependent upon 
Exposure 10 "peak" concentra-
tion of [14C]DCE 
(see Fig. 4 for time-course) 
Ratno. 3 Ratno.4 
0.097 0.10 
0.29 0.33 
96 104 
348 342 
322 330 
31 36 
Ratno. 3 Ratno.4 
134 81 
6 6 
94 94 
29 34 
Controls 
Background 
radioactivity 
R.atno.5 
0.33 
13.4 
0 
0 
Ratno. 5 
Binding 
in vitro 
Rat no. 6 
0.35 
15.0 
0 
0 
Rat no. 6 
the concentration-time course. With peak concentrations 
reaching up to 4400 ppm in the atmosphere for a few 
minutes, the CBI was 69 for liver DNA and 31 for lung 
DNA. The other inhalation regimen, a constant concentra-
tion level of about 80 ppm for 4 h, resulted in CBI values 
lower by a factor of about 40, both for Ii ver and lung. 
The Iiterature values on DNA binding potency after 
injection of DCE are in accordance with the binding 
potency of our "peak" exposure regimen: Inskeep and co-
workers (1986) have treated rats with a single dose of 
150 mg/kg [1,2-14C]DCE by i. p. injection and have isolat-
ed DNA 8 h later. In the liver, neutral thermal hydrolysis to 
depurinate 7-alkylguanines released 78% of the DNA ra-
dioactivicy. HPLC analysis showed one majorpeak migrat-
ing with synthetically prepared S-[2-(guanyl-7)ethyl]-glu-
tathione. Two minor radioactivity peaks were also present, 
one of which was identified as S-[2-(guanyl-7)ethyl]-cys-
teinylglycine. This structural diversity of adducts could 
also explain the different peaks found in the present study 
(Figs. 5 and 6). Expressed in the units of the CBI and 
assuming complete metabolism of the administered dose, a 
value of 40 can be calculated for the liver. 
Arfellini and coworkers ( 1984) have published a CBI 
value of 47 in rat Ii ver DNA, after i. p. administration of 
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Fig. S. Reverse phase HPLC elution proflies of deox.yribonucleotides 
obtained by enzymatic hydro1yses of DNA isolated from F-344 rats 
following inhalation exposures to "constant-low" concentrations of l,2-
[14C)dichloroethane. A Absorbance at 254 nm, representing the normal 
3'-nucleotides in the order dCp, dGp+Tp, dAp (liver DNA sample ofrat 
no. 2 shown). B [14C]Radioactivity profile (liver DNA of rat no. 2). 
DNA adducts eluting in hatched bars with specific radioactivities 
>550 dpm/mg. Open bars: 10 dpm/mg dGp and 28 dpm/mg d.Ap. 
C [14C]Radioactivity profile (Jung DNA of pool of rats nos I and 2). 
Specific radioactivities of > 115 and 15 -19 dpm/mg were measured in 
hatched and open bars, respectively 
DCE to rats. Since they did not account for the Ievel of 
biosynthetic incorporation ofradiolabel into DNA, the true 
adduct value could be slightly lower. 
Metabolie activation and inactivation 
DCE is weakly electrophilic. This reactivity fonns the 
basis of a weak activation independent (direct) mutagenic-
ity in the Ames test. Our findings could therefore be inter-
preted in terms of a saturation of enzymatic detoxication 
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Fig. 6. Reverse phase HPLC elution profiles of deoxyribonucleotides 
obtained by enzymatic hydrolyses of DNA isolated from F-344 rats 
following inhalation exposures to "peak" concentrations of 1,2-
[14C]dichloroethane. See Fig. SA for characteristic absorbance profile of 
normal nucleotides. B [I'*C]Radioactivity profile (liver DNA of rat 
no. 3). The hatched bars had specific activities >40'000 dpm/mg and 
represent adducts, the open bar showed 180 dpm{mg. C ['4C)Radioac-
tivity profile (lung DNA of rat no. 4 ). The specific radioactivites found in 
hatched and open bars were >1070 and 95 dpm/mg, respectively 
above a certain blood Ievel. This explanation cannot be 
accepted unconditionally because it has been shown that 
conjugation with glutathione can generate a more reactive 
electrophile than the parent compound. This situation is 
opposed to the general understanding of glutathione action 
and is specific for 1 ,2-dihaloalkanes. Conjugation with 
glutathione is not, therefore, a simple inactivation pathway 
in this case, and saturation does not have to result in an 
increased DNA damage. Another complicating factor is the 
fact that a cytochrome P450-dependent pathway can Iead 
to 2-chloroacetaldehyde which can also react with macro-
molecules. It is therefore as yet unknown whether some 
inactivation pathway is saturated at high blood Ievels or 
whether processes activating DCE to more dangeraus 
DNA-binding metabolites might operate effectively only 
above a certain concentration. 
Oral versus inhalation exposure 
Different genotoxic potency of DCE by the bolus-like ad-
ministrations (gavage and i. p. injection) versus inhalation 
has been reported before (Storer et al. 1984 ). Single-strand 
breaks and alkali-labile lesions in hepatic DNA were de-
monstrated 4 h after p. o. and i. p. administration of 100-
150 mg/kg, but not after inhalation at up to 500 ppm. In-
halation exposures to 1000 and 2000 ppm DCE caused 
high mortality after 24 h and damaged DNA within 4 h, but 
the possibility that this darnage was due to the acute necro-
176 
genic effects was not excluded. The different Ievel of DNA 
adduct formation determined in this study is in good agree-
ment with their investigation. The dose metabolized in our 
"peak" inhalation exposure was similar to the dose which 
Storerand coworkers administered by gavage; both models 
of administration probably resulted in a rapid initial in-
crease of DCE in the blood. 
The present study indicates that the genotoxic potency 
of 1,2-dichloroethane strongly depends upon the dosing 
regimen. The carcinogenic potency determined in the gav-
age study should not, therefore, be used for low-level in-
.halation exposure. 
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